Late DLEK failure patients benefit from repeat endothelial keratoplasty

Article

Repeat endothelial keratoplasty (EK) is effective in improving corneal clarity in patients with failed deep lamellar endothelial keratoplasty (DLEK).

Repeat endothelial keratoplasty (EK) is effective in improving corneal clarity in patients with failed deep lamellar endothelial keratoplasty (DLEK), declares a study published in Cornea.

Dr Peter Kim et al., Department of Ophthalmology, Toronto Western Hospital, University of Toronto, Canada, compiled a retrospective, interventional case series on 10 eyes of 9 patients. Clinical records were reviewed of all participants who experienced failed DLEK surgery and underwent repeat EK surgery. Of the patients included in the study, 7 eyes had their failed DSEK donor disc removed and 3 eyes underwent repeat EK without the removal of the failed donor disc.

All eyes saw vast improvements in corneal clarity and visual acuity. There were no significant postoperative complications recorded after EK surgery.

It was concluded that repeat EK is a suitable and effective alternative to penetrating keratoplasty (PK). Surgery can be performed with or without removing the failed donor disc.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.